DBH and COVID-19: The expression levels of DBH-AS1, FLVCR1-DT, the antisense long non-coding RNA of FLVCR1 and NCBP2AS2-1, and the antisense long non-coding RNA of NCBP2 in COVID-19 patients in this study were deregulated, with a significant increase in both patient groups in comparison with controls.